PCG
Private Capital Group Portfolio holdings
AUM
$133M
1-Year Return
11.23%
This Quarter Return
+6.28%
1 Year Return
-11.23%
3 Year Return
+30.08%
5 Year Return
–
10 Year Return
–
AUM
$403M
AUM Growth
-$140M
(-26%)
Cap. Flow
-$170M
Cap. Flow
% of AUM
-42.26%
Top 10 Holdings %
Top 10 Hldgs %
35.82%
Holding
2,304
New
127
Increased
334
Reduced
1,092
Closed
178
Top Buys
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$18.2M |
| 2 |
Vanguard Mid-Cap Growth ETF
VOT
|
$8.02M |
| 3 |
Vanguard Mid-Cap Value ETF
VOE
|
$7.58M |
| 4 |
Vanguard Growth ETF
VUG
|
$6.92M |
| 5 |
Vanguard Value ETF
VTV
|
$6.57M |
Sector Composition
| 1 | Technology | 6.89% |
| 2 | Financials | 4.31% |
| 3 | Healthcare | 3.71% |
| 4 | Consumer Discretionary | 3.5% |
| 5 | Industrials | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Lam Research
LRCX
$130B
| $192K | 0.05% |
3,220
-4,280
| -57% | -$255K |
|
227
IPG Photonics
IPGP
$3.56B
| $188K | 0.05% |
889
+373
| +72% | +$78.9K |
|
228
iShares ESG Aware MSCI EAFE ETF
ESGD
$9.93B
| $187K | 0.05% |
2,469
+186
| +8% | +$14.1K |
|
229
Gilead Sciences
GILD
$143B
| $185K | 0.05% |
2,857
-317
| -10% | -$20.5K |
|
230
Envista
NVST
$3.54B
| $181K | 0.04% |
4,427
-289
| -6% | -$11.8K |
|
231
Nucor
NUE
$33.8B
| $176K | 0.04% |
2,191
+726
| +50% | +$58.3K |
|
232
Novartis
NVS
$251B
| $176K | 0.04% |
2,057
-2,153
| -51% | -$184K |
|
233
General Mills
GIS
$27B
| $174K | 0.04% |
2,836
+110
| +4% | +$6.75K |
|
234
RELX
RELX
$85.9B
| $174K | 0.04% |
6,930
-755
| -10% | -$19K |
|
235
AdvisorShares Insider Advantage ETF
SURE
$49.6M
| $173K | 0.04% |
1,931
| – | – |
|
236
Wabtec
WAB
$33B
| $171K | 0.04% |
2,160
+382
| +21% | +$30.2K |
|
237
Diageo
DEO
$61.3B
| $170K | 0.04% |
1,025
-1,960
| -66% | -$325K |
|
238
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $170K | 0.04% |
2,559
-366
| -13% | -$24.3K |
|
239
Blackrock
BLK
$170B
| $168K | 0.04% |
223
-203
| -48% | -$153K |
|
240
Unilever
UL
$158B
| $166K | 0.04% |
2,967
-2,100
| -41% | -$117K |
|
241
Novo Nordisk
NVO
$245B
| $164K | 0.04% |
4,810
-14,850
| -76% | -$506K |
|
242
Health Care Select Sector SPDR Fund
XLV
$34B
| $164K | 0.04% |
1,402
| – | – |
|
243
Crown Castle
CCI
$41.9B
| $163K | 0.04% |
949
-500
| -35% | -$85.9K |
|
244
Emergent Biosolutions
EBS
$404M
| $160K | 0.04% |
1,721
-189
| -10% | -$17.6K |
|
245
Hilton Worldwide
HLT
$64B
| $160K | 0.04% |
1,322
-912
| -41% | -$110K |
|
246
Cadence Design Systems
CDNS
$95.6B
| $159K | 0.04% |
1,159
-959
| -45% | -$132K |
|
247
Cheniere Energy
LNG
$51.8B
| $159K | 0.04% |
2,202
-75
| -3% | -$5.42K |
|
|
ALXN
248
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $159K | 0.04% |
1,043
-1,122
| -52% | -$171K |
|
249
Vanguard S&P Small-Cap 600 ETF
VIOO
$3.05B
| $158K | 0.04% |
1,586
| – | – |
|
|
SYNH
250
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $158K | 0.04% |
2,088
-1,077
| -34% | -$81.5K |
|